异烟肼在多壁碳纳米管修饰碳糊电极上的电化学行为及其应用

通过研究异烟肼在多壁碳纳米管修饰碳糊电极上的电化学行为建立了测定异烟肼的电化学方法。在pH6.8的磷酸氢二钠–柠檬酸缓冲溶液中,异烟肼在–1.114 V处能产生一明显还原峰,异烟肼在修饰电极上的反应是受吸附控制的2质子、2电子电极反应过程。研究发现还原峰峰电流大小与异烟肼浓度在5.00×10~(-3)~5.00 mmol/L内呈良好的线性关系,相关系数r=0.997 0,方法检出限为1.70×10~(-3) mmol/L,测定结果的相对标准偏差为3.11%(n=5),回收率为97.6%~103.6%。该方法简单、灵敏,精密度高,可应用于样品中异烟肼的测定。     

A flow injection chemiluminescence system for the determination of isoniazid

A chemiluminescence (CL) flow system is described for the determination of isoniazid based on its enhancement on the chemiluminescence (CL) emission produced upon mixing a hexacyanoferrate(III) solution with an alkaline luminol solution. The system responds linearly to isoniazid concentration in the range 0–1 mg/L with a detection limit (3σ) of 0.03 μg/L, relative standard deviation (RSD) of 1.2% for 0.1 mg/L isoniazid (n = 11). The system has been successfully applied to the determination of isoniazid in pharmaceutical preparations.     

Flow injection chemiluminescence determination of isoniazid with electrogenerated hypochlorite

A flow-injection chemiluminescence method for the determination of isoniazid based on the sensitizing effect of isoniazid on the chemiluminescence generating luminol-hypochlorite reaction is described. The hypochlorite was electrogenerated on-line by constant current electrolysis, thus, eliminating instability of hypochlorite solution prepared from commercially available sodium hypochlorite. The calibration graph is linear in the range 1 × 10^–8 to 1 × 10^–6 g mL^–1, and the detection limit is 6 × 10^–9 g mL^–1. The relative standard deviation for determination of 5 × 10^–8 g mL^–1 is 2.8%. The proposed method has been successfully applied to the determination of isoniazid in pharmaceutical preparations.     

Titrimetric microdetermination of isoniazid by amplification reactions

An amplification method for the determination of (0.01–2.0 mg) isoniazid is described. It depends on oxidation of the isoniazid sample solution with a chloroform solution of iodine and removed of its excess, oxidation of the resulting iodide with bromine, and iodometric titration of the liberated iodate after 6-fold amplification. Alternatively, the liberated iodine is reduced to iodide, and again oxidized to yield 36 iodide ions for every iodide ion originally present. The coefficient of variation does not usually exceed 1.5% for above 0.5 mg of isoniazid but increases to 3.6% at the 0.01-mg level.     

HPLC–MS Analysis of Isoniazid in Dog Plasma

A simple, rapid, and sensitive liquid chromatography–mass spectrometric (LC–MS) method was developed and validated for the determination of isoniazid in dog plasma. Plasma samples were deproteined with methanol and separated on a C₁₈ column interfaced with a single quadrupole mass spectrometer, using 0.1% formic acid–acetonitrile (91:9 v/v) as mobile phase. Detection was performed by positive electrospray ionization with selected ion monitoring at m/z 138 for isoniazid and 152 for entecavir maleate internal standard. Linearity was obtained over the range of 25–5,000 ng mL^?1, with a lower limit of quantification of 25 ng mL^?1. The intra- and inter-day precision was less than 2.7% in terms of relative standard deviation. Accuracy, expressed as relative error, ranged from ?2.0 to 8.0%. Plasma samples were analysed within 5 min. The method was successfully applied to the evaluation of the pharmacokinetics of isoniazid in dog plasma.     

以Cu(II)为光谱探针离子分光光度法测定异烟肼的新方法

以Cu(II)为光谱探针建立了一种高选择性、高灵敏度测定异烟肼的新方法。试验表明：在pH 6.0时，Cu(II)可被异烟肼还原生成Cu(I)，反应生成的Cu(I) 与SCN-反应生成CuSCN白色乳状沉淀，在硝酸钠的存在下该沉淀可被浮选至水相表面。通过测定水相中剩余Cu(II)的量，可以间接测定异烟肼的含量。已反应Cu(II) 的量与异烟肼的浓度呈良好的线性关系，线性范围为0.050-4.50 µg mL-1，检出限为0.048 µg mL-1。该法已经成功的用于药物样品和病人尿液样品中异烟肼含量的测定。     

Adsorption of isoniazid onto sepiolite–palygorskite group of clays: An IR study

The adsorption of isoniazid (INH) on sepiolite, loughlinite (natural Na-sepiolite) and palygorskite from Anatolia was investigated by FT-IR spectroscopy. Experimental results indicated that INH molecules, adsorbed on sepiolite–palygorskite group of clays, are coordinated to surface hydroxyls by H-bonding interaction through the pyridine ring nitrogen lone pairs. Moreover, some of the adsorbed INH molecules may enter the interior channels of the sepiolite–palygorskite structure and involve H-bonding interaction with zeolitic water. Some intensity and frequency changes in the OH stretching band of surface hydroxyls (Si–OH) of the INH-treated sepiolite and loughlinite were observed. However, this band is found to be less affected by the adsorption of isoniazid in the case of palygorskite, probably because the surface Si–OH groups in palygorskite appear to be less abundant than in sepiolite or loughlinite.     

Cinnamic acid hydrogen bonds to isoniazid and N′‐(propan‐2‐ylidene)isonicotinohydrazide,an in situ reaction product of isoniazid and acetone

A new polymorph of the cinnamic acid–isoniazid cocrystal has been prepared by slow evaporation, namely cinnamic acid–pyridine‐4‐carbohydrazide (1/1), C₉H₈O₂·C₆H₇N₃O. The crystal structure is characterized by a hydrogen‐bonded tetrameric arrangement of two molecules of isoniazid and two of cinnamic acid. Possible modification of the hydrogen bonding was investigated by changing the hydrazide group of isoniazid via an in situ reaction with acetone and cocrystallization with cinnamic acid. In the structure of cinnamic acid–N′‐(propan‐2‐ylidene)isonicotinohydrazide (1/1), C₉H₈O₂·C₉H₁₁N₃O, carboxylic acid–pyridine O—H...N and hydrazide–hydrazide N—H...O hydrogen bonds are formed.     

LC–QToF–MS method for quantification of ethambutol,isoniazid, pyrazinamide and rifampicin in human plasma and its application

In this research, we developed and validated a liquid chromatography coupled to mass spectrometry (LC–QToF–MS) method for simultaneous quantification of the anti-tuberculosis drugs ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma. Plasma samples spiked with cimetidine (internal standard) were extracted using protein precipitation with acetonitrile containing 1% formic acid. Separation was performed using a C₁₈ column under flow gradient conditions with water and acetonitrile, both containing 5 mm ammonium formate and 0.1% formic acid. The method was validated according to the ANVISA and US Food and Drug Administration guidelines for bioanalytical method validation. The calibration curve was linear over a concentration range of 0.2–5 μg ml⁻¹ for ethambutol, 0.2–7.5 μg ml⁻¹ for isoniazid, 1–40 μg ml⁻¹ for pyrazinamide and 0.25–2 μg ml⁻¹ for rifampicin, all with adequate precision and accuracy. The method was reproducible, selective and free of carryover and matrix effects. The validated LC–QToF–MS method was successfully applied to real samples and shown to be applicable to future therapeutic and pharmacokinetic monitoring studies.     

Efficient electrocatalytic oxidation and selective determination of isoniazid by Fe(tmphen) 3 2+ -exchanged Nafion?-modified electrode

Cyclic voltammetry and electrochemical impedance studies of Fe(tmphen) ₃ ²⁺ (where tmphen?=?3,4,7,8-tetramethyl-1,10-phenanthroline)-immobilized Nafion?-modified glassy carbon electrode (GC/Nf/Fe(tmphen) ₃ ²⁺ ) are carried out in 0.1?M Na₂SO₄ solution. Nafion–Fe(tmphen) ₃ ²⁺ complex exhibits efficient electrocatalytic oxidation of isoniazid. The linear double reciprocal plot of current and concentration of isoniazid shows a Michaelis–Menten-type catalytic process. The catalytic oxidation currents are proportional to the concentration of isoniazid and show a wide linear calibration range for the quantitative determination of isoniazid. Detection limit and sensitivity are found to be 13?μM and 2.5?μA?mM^?1, respectively.     

One-Pot Ozonolytic Synthesis of Isoniazid Derivatives from (–)-α-Pinene and Δ<Superscript>3</Superscript>-Carene

Optically active isoniazid derivatives containing a cyclopropane or cyclobutane fragment have been synthesized by ozonolysis of (+)-Δ³-carene and (–)-α-pinene, followed by treatment of the ozonolysis products with isonicotinic acid hydrazide.     

Design,Synthesis, and Antimycobacterial Activities of Diethylene Glycol Tethered Moxifloxacin–Isatin Hybrids

A new class of diethylene glycol tethered moxifloxacin–isatin hybrids 5a–l was designed, synthesized, and evaluated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis (MTB) H37Rv and multidrug‐resistant tuberculosis (MDR‐TB) strains. Our results showed that all hybrids with higher lipophilicity than the parent moxifloxacin exhibited promising activity against the tested strains with minimum inhibitory concentration (MIC) in a range of 0.2–16 μg/mL. In particular, hybrid 5h (MIC: 0.20 and 0.5 μg/mL), which was found to be most active against MTB H37Rv and MDR‐TB, was twofold more potent than isoniazid (MIC: 0.39 μg/mL) against MTB H37Rv and ≥64‐fold more active than isoniazid and rifampicin (MIC: >128 and 32 μg/mL, respectively) against MDR‐TB.     

Simultaneous Determination of Isoniazid and Acetylisoniazid in Human Plasma by Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry and Its Application to a Pharmacokinetics Related to N-Acetyltransferase2 Genetic Polymorphism

A rapid, sensitive, and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method with hydrophilic interaction chromatography has been developed and validated for the simultaneous determination of isoniazid and acetylisoniazidin human plasma. Following precipitation of the protein, the analytes were extracted from human plasma, with high extraction recovery (>70%) for both Isoniazid and acetylisoniazid. The analytes were then separated using a hydrophilic interaction chromatography (HILIC) column and detected by electrospray ionization (ESI) mass spectrometry performed with a triple-quadrupole mass spectrometry. The quantification of the analytes was realized by low-energy collision dissociation tandem mass spectrometry (CID-MS/MS) using the multiple reaction monitoring (MRM) mode at m/z of 138.1→121.1 for isoniazid and m/z 180.1 → 138.1 for acetylisoniazid, respectively. The method was linear over the concentration range of 5–50,000 ng/mL for both. The intra-day and inter-day relative standard deviations (RSD) were less than 15% and the relative errors (RE) were all within 15%. The validated method has been successfully used to analyze human plasma samples for application in pharmacokinetic studies of isoniazid related to NAT2 genetic polymorphism in healthy Chinese subjects. The results showed that there were significant differences in the pharmacokinetic parameters of isoniazid and acetylisoniazid between subjects with and without mutations in the NAT2 gene.     

Design of an optical sensor for indirect determination of isoniazid

The characterization of an optical sensor membrane is described for indirect determination of isoniazid. The sensing membrane was consisted of immobilized 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine (PDT) on a triacetylcellulose membrane. The procedure is based on the reaction of Fe(III) with isoniazid in the presence of PDT. Fe(III) is reduced by isoniazid to Fe(II) which forms a complex with PDT. The complex shows an absorption maximum at 558nm. By measuring the absorbance of the complex at this wavelength, isoniazid can be determined in the range of 0.62-6.15mugmL(-1). This method was applied to the determination of isoniazid in pharmaceutical formulation and enabled the determination of isoniazid in microgram quantities.     

Host–guest complexes of the antituberculosis drugs pyrazinamide and isoniazid with cucurbit[7]uril

The potential use of cucurbit[7]uril (CB[7]) as an excipient in oral formulations for improved drug physical stability or for improved drug delivery was examined with the antituberculosis drugs pyrazinamide (pyrazine-2-carboxamide) and isoniazid (isonicotinohydrazide). Both drugs form 1:1 host–guest complexes with CB[7] as determined by ¹H nuclear magnetic resonance spectrometry, electrospray ionisation mass spectrometry and molecular modelling. Drug binding is stabilised by hydrophobic effects between the pyridine and pyrazine rings of isoniazid and pyrazinamide, respectively, to the inside cavity of the CB[7] macrocycle as well as hydrogen bonds between the hydrazide and amide groups of each drug to the CB[7] carbonyl portals. At pH 1.5, isoniazid binds CB[7] with a binding constant of 5.6 × 10⁵ M^?1, whilst pyrazinamide binds CB[7] at pH 7 with a much smaller binding constant (4.8 × 10³ M^?1). Finally, CB[7] prevents drug melting through encapsulation. Where previously pyrazinamide displays a typical melting point of 189 °C and isoniazid 171 °C, by differential scanning calorimetry, no melting or degradation at temperatures up to 280 °C is observed for either drug once bound by CB[7].     

Determination of isoniazid in drugs

A titrimetric method is described for the determination of isoniazid in pharmaceutical preparations. Samples are treated with an excess of iodine monochloride, and the iodine produced is titrated with iodine trichloride to an Andrews end-point. p-Aminosalicylic acid undergoes only nuclear iodination and does not interfere. Mixtures of isoniazid with vitamin C or methionine are analysed by first titrating both compounds by the Andrews method and then determining either vitamin C alone by titration with iodine monochloride or methionine by a second Andrews titration after destruction of isoniazid with nitrous acid. In both cases, isoniazid is obtained by difference. A mixture of isoniazid, methionine and vitamin C can also be analysed.     

Oxidation of isoniazid by quinolinium dichromate in an aqueous acid medium and kinetic determination of isoniazid in pure and pharmaceutical formulations.

The kinetics of oxidation of isoniazid in acidic medium was studied spectrophotometrically. The reaction between QDC and isoniazid in acid medium exhibits (4:1) stoichiometry (QDC:isoniazid). The reaction showed first order kinetics in quinolinium dichromate (QDC) concentration and an order of less than unity in isoniazid (INH) and acid concentrations. The oxidation reaction proceeds via a protonated QDC species, which forms a complex with isoniazid. The latter decomposes in a slow step to give a free radical derived from isoniazid and an intermediate chromium(V), which is followed, by subsequent fast steps to give the products. The reaction constants involved in the mechanism are evaluated. Isoniazid was analyzed by kinetic methods in pure and pharmaceutical formulations.     

Sensitive indirect spectrophotometric determination of isoniazid

A simple, rapid, sensitive and accurate indirect spectrophotometric method for the microdetermination of isoniazid (INH) in pure form and pharmaceutical formulations is developed. The procedure is based on the reaction of copper(II) with isoniazid in the presence of neocuproine (NC). In the presence of neocuproine, copper(II) is reduced easily by isoniazid to a Cu(I)-neocuproine complex, which shows an absorption maximum at 454 nm. By measuring the absorbance of the complex at this wavelength, isoniazid can be determined in the range 0.3-3.5 microgml-1. This method was applied to the determination of isoniazid in pharmaceutical formulation and enabled the determination of the isoniazid in microgram quantities (0.3-3.5 microgml-1). The results obtained for the assay of pharmaceutical preparations compared well with those obtained by the official method and demonstrated good accuracy and precision.     

Oxidation of Antitubercular Drug Isoniazid by a Lipopathic Oxidant,Cetyltrimethylammonium Dichromate: A Mechanistic Study

The oxidation of an antitubercular drug isoniazid by a lipopathic oxidant cetyltrimethylammonium dichromate (CTADC) in a nonpolar medium generates isonicotinic acid both in the presence and the absence of acetic acid. The conventional UV–vis spectrophotometric method is used to study the reaction kinetics. The occurrence of the Michaelis–Menten–type kinetics with respect to isoniazid confirms the binding of oxidant and substrate to form a complex before the rate‐determining step. The existence of the inverse solvent kinetic isotope effect, k(H₂O)/ k(D₂O) = 0.7, in an acid‐catalyzed reaction proposes a multistep reaction mechanism. A decrease in the rate constant with an increase in [CTADC] reveals the formation of reverse micellar–type aggregates of CTADC in nonpolar solvents. In the presence of different ionic and nonionic surfactants, CTADC forms mixed aggregates and controls the reaction due to the charge on the interface and also due to partition of oxidant and substrate in two different domains. High negative entropy of activation (ΔS^? = –145 and –159 J K^?1 mol^?1 in the absence and presence of acetic acid) proposes a more ordered and highly solvated transition state than the reactants. Furthermore, the solvent polarity‐reactivity relationship reveals (i) the presence of less polar and less ionic transition state compared to the reactants during the oxidation, (ii) differential contribution from nonpolar and dipolar aprotic solvents toward the reaction process, and (iii) the existence of polarity/hydrophobic switch at log P = 0.73. A suitable mechanism has been proposed on the basis of experimental results. These results may provide insight into the mechanism of isoniazid oxidation in hydrophobic environment and may assist in understanding the drug resistance in different location.     

Multi-walled carbon nanotube paste electrode for selective voltammetric detection of isoniazid

A multi-walled carbon nanotube paste electrode (MWCPE) is prepared as an electrochemical sensor with high sensitivity and selectivity in responding to isoniazid. The electrochemical oxidation of isoniazid is investigated in buffered solution by cyclic and differential pulse voltammetry. The electrode is shown to be very effective for the detection of isoniazid in the presence of other biological reductant compounds. The electrochemical oxidation of cysteine, due to the high overvoltage, is completely stopped at the surface of MWCPE. The electrode exhibits a very good resolution between the voltammetric peak of isoniazid and the peaks of ascorbic acid (AA) and dopamine (DA). A resolution of more than 450 mV between the anodic peak potentials makes the MWCPE suitable for simultaneous detection of isoniazid in the presence of AA or DA in clinical and pharmaceutical preparations. Differential pulse voltammetry (DPV) is applied as a sensitive method for the determination of isoniazid. The linear range in these determinations is 1 × 10⁻⁶–1 × 10⁻³ M for isoniazid and the detection limit is 5 × 10⁻⁷ M. The electrode was applied to the simultaneous determinations in isoniazid and AA mixtures and also, isoniazid and DA mixture over a wide concentration range. The slope variation for the calibration curves of isoniazid (RSD) was less than 4.5% (based on ten measurements over a period of three months).